Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»BioTech»Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
    BioTech

    Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah

    Marie JonesBy Marie JonesSeptember 21, 2022No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Parties agree to collaborate on research in genetics, regenerative and alternative medicine

    Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines.

    Chairman of Malaysian Genomics, Datuk Seri Dr. Chen Chaw Min

    Under the LOI, MGRC, which owns a high-throughput sequencing lab, advanced microarray facility, and new state-of-the-art cell processing lab, as well as Genotec, which specializes in biomedical treatments using stem cells, will assist in strengthening the teaching and research activities of the undergraduate programme at UMS’ Faculty of Science and Natural Resources.

    This cooperation will enable the exchange of research resources and ideas to enhance the quality of research at UMS, as well as create opportunities for students from the Faculty of Science and Natural Resources to serve their internship period at MGRC or Genotec.

    Chairman of Malaysian Genomics, Datuk Seri Dr. Chen Chaw Min, said, “We are happy to assist UMS undergraduates in pursuing their R&D goals so that they have a better understanding of their field of study. This is also in support of the National Biotechnology Policy 2.0 launched recently focusing on agriculture and food security, healthcare and wellbeing, as well as industrial and the circular economy.”

    The Dean of the Faculty of Science and Natural Resources, UMS, Professor Dr. Jualang Azlan Gansau said, “UMS is actively engaging in research as well as teaching activities and the involvement of industry is crucial in ensuring the relevance of such activities conducted at the University.”

    The signing of the LOI followed UMS’ visit to MGRC’s Biosafety Level 2 cGMP (Current Good Manufacturing Practice)-certified laboratory, which is used for the production of cell therapies, including CAR T-cell therapies for various cancers.

    Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC: MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/

    Malaysian Genomics Resource Centre Berhad
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleValue Research Center, Kyoto at the UNGA77 Science Summit
    Next Article Dah Sing Bank and Friends of the Earth (HK) Jointly Present Retail and E-Commerce ESG Forum for SMEs

    Related Posts

    Accrelist Appoints Derek Cheong as Chief Executive Officer

    June 17, 2026

    Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia

    June 16, 2026

    Japantastics Introduces Sato Mokko to the World — A New Chapter in Japanese Artisanal Craftsmanship

    June 16, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.